No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis.

Source:http://linkedlifedata.com/resource/pubmed/id/16769786

Download in:

View as

General Info

PMID
16769786